CYP 2.50% 19.5¢ cynata therapeutics limited

Ann: Cynata Expands trial in COVID-19 & Respiratory Failure, page-2

  1. 440 Posts.
    lightbulb Created with Sketch. 148
    Isn't this good news!!
 
watchlist Created with Sketch. Add CYP (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.